Magnetic Resonance Imaging (MRI) Contrast Agents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Description

List of Tables

GlobalData's Medical Devices sector report, "Magnetic Resonance Imaging (MRI) Contrast Agents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Magnetic Resonance Imaging (MRI) Contrast Agents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Magnetic Resonance Imaging (MRI) utilizes radiofrequency and a strong magnetic field to generate clear and detailed images of internal organs and tissues. MRI is generally preferred for the diagnosis of brain and other neurological disorders.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Magnetic Resonance Imaging (MRI) Contrast Agents under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Magnetic Resonance Imaging (MRI) Contrast Agents and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Magnetic Resonance Imaging (MRI) Contrast Agents under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date

Product Code: GDME1842EPD

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Magnetic Resonance Imaging (MRI) Contrast Agents Overview

3 Products under Development

3.1 Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products by Stage of Development
3.2 Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products by Segment
3.3 Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products by Territory
3.4 Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products by Regulatory Path
3.5 Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products by Estimated Approval Date
3.6 Magnetic Resonance Imaging (MRI) Contrast Agents - Ongoing Clinical Trials

4 Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products under Development by Companies

4.1 Magnetic Resonance Imaging (MRI) Contrast Agents Companies - Pipeline Products by Stage of Development
4.2 Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products by Stage of Development

5 Magnetic Resonance Imaging (MRI) Contrast Agents Companies and Product Overview

6 Magnetic Resonance Imaging (MRI) Contrast Agents- Recent Developments

7 Appendix

7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

Product Code: GDME1842EPD

List of Tables

Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products by Stage of Development
Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products by Segment
Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products by Territory
Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products by Regulatory Path
Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products by Estimated Approval Date
Magnetic Resonance Imaging (MRI) Contrast Agents - Ongoing Clinical Trials
Magnetic Resonance Imaging (MRI) Contrast Agents Companies - Pipeline Products by Stage of Development
Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products by Stage of Development
5M Biomed LLC Pipeline Products & Ongoing Clinical Trials Overview
Surface Functionalized Magnetic Iron Oxide Nanorods - Product Status
Surface Functionalized Magnetic Iron Oxide Nanorods - Product Description
Water Soluble Magnetic Iron Oxide Nanocubes - Product Status
Water Soluble Magnetic Iron Oxide Nanocubes - Product Description
Adamas Nanotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Photo-Hyperpolarizable Nanodiamond-Based 13C Contrast Agent - Product Status
Photo-Hyperpolarizable Nanodiamond-Based 13C Contrast Agent - Product Description
Alzeca Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
ADx Nanoparticle - Product Status
ADx Nanoparticle - Product Description
Alzeca Biosciences Inc - Ongoing Clinical Trials Overview
ADx Nanoparticle - A Phase 1, Controlled, Open-label, Single Dose, Dose-escalation, Clinical Proof-of-concept Study of MRI Enhanced With ADx-001 (DSPE-DOTA-Gd Liposomal Injection) in Patients with Brain Amyloid Deposits as Demonstrated by Amyloid PET
Antaros Medical AB Pipeline Products & Ongoing Clinical Trials Overview
Gadoxetate DCE-MR Imaging Agent - Liver Toxicity - Product Status
Gadoxetate DCE-MR Imaging Agent - Liver Toxicity - Product Description
Ascelia Pharma AB Pipeline Products & Ongoing Clinical Trials Overview
Orviglance - Product Status
Orviglance - Product Description
Second Generation Mangoral - Product Status
Second Generation Mangoral - Product Description
Ascelia Pharma AB - Ongoing Clinical Trials Overview
Orviglance - Study Evaluate the Influence of Hepatic Impairment on the Safety, Pharmacokinetics and Pharmacodynamics of Mangoral
B-Aegis Life Sciences & Research Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
OncoSense - Product Status
OncoSense - Product Description
Bayer AG Pipeline Products & Ongoing Clinical Trials Overview
Gadoquatrane Contrast Agent - Product Status
Gadoquatrane Contrast Agent - Product Description
Next Generation Liver MRI Contrast Agent - Product Status
Next Generation Liver MRI Contrast Agent - Product Description
BBS NanoTechnology Ltd Pipeline Products & Ongoing Clinical Trials Overview
FCA1 - Gd Containing Paramagnetic MR T1 Contrast Agent - Product Status
FCA1 - Gd Containing Paramagnetic MR T1 Contrast Agent - Product Description
Brown University Pipeline Products & Ongoing Clinical Trials Overview
MR Imaging Probe - Cancer - Product Status
MR Imaging Probe - Cancer - Product Description
Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview
AI Contrast Agent - Product Status
AI Contrast Agent - Product Description
ZD2-Gd3N@C80 - Product Status
ZD2-Gd3N@C80 - Product Description
EOS Biosciences Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Eos-002 - Product Status
Eos-002 - Product Description
Eos-004 - Product Status
Eos-004 - Product Description
Ferric Contrast Inc Pipeline Products & Ongoing Clinical Trials Overview
K720 - Kidney Tumors - Product Status
K720 - Kidney Tumors - Product Description
L410 - Liver Tumor - Product Status
L410 - Liver Tumor - Product Description
MP89 - Multipurpose - Product Status
MP89 - Multipurpose - Product Description
GE HealthCare Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Manganese-Based Macrocyclic Magnetic Resonance Imaging (MRI) Contrast Agent - Product Status
Manganese-Based Macrocyclic Magnetic Resonance Imaging (MRI) Contrast Agent - Product Description
GE HealthCare Technologies Inc - Ongoing Clinical Trials Overview
Manganese-Based Macrocyclic Magnetic Resonance Imaging (MRI) Contrast Agent - A Phase I Study to Assess the Safety Profile of Injectable Manganese Contrast Agent
Georgia State University Pipeline Products & Ongoing Clinical Trials Overview
Protein Contrast Agent - Product Status
Protein Contrast Agent - Product Description
Hana Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
HNP-2006 - Product Status
HNP-2006 - Product Description
Harvard University Pipeline Products & Ongoing Clinical Trials Overview
Hyperpolarized MRI Contrast Agent - Product Status
Hyperpolarized MRI Contrast Agent - Product Description
Hugo W. Moser Research Institute at Kennedy Krieger Inc Pipeline Products & Ongoing Clinical Trials Overview
D-Glucose Contrast Agent - Product Status
D-Glucose Contrast Agent - Product Description
IC Targets AS Pipeline Products & Ongoing Clinical Trials Overview
Mangafodipir - Product Status
Mangafodipir - Product Description
IC Targets AS - Ongoing Clinical Trials Overview
Mangafodipir - Investigation of Blood-brain-barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-resistant Epilepsy
Imagion Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
MagSense HER2+ Breast Cancer Imaging Agent - Product Status
MagSense HER2+ Breast Cancer Imaging Agent - Product Description
Magsense Prostate Cancer Imaging Agent - Product Status
Magsense Prostate Cancer Imaging Agent - Product Description
iMax Diagnostic Imaging Ltd Pipeline Products & Ongoing Clinical Trials Overview
Gadopentetate Dimeglumine - Product Status
Gadopentetate Dimeglumine - Product Description
Macrocyclic MRI Contrast Agent - Product Status
Macrocyclic MRI Contrast Agent - Product Description
Indian Institute of Technology Delhi Pipeline Products & Ongoing Clinical Trials Overview
MRI Imaging Iron Nano-Particles - Product Status
MRI Imaging Iron Nano-Particles - Product Description
Inlighta Biosciences LLC Pipeline Products & Ongoing Clinical Trials Overview
Novel Contrast Agent - Lung Fibrosis - Product Status
Novel Contrast Agent - Lung Fibrosis - Product Description
ProCA32.Collagen - Product Status
ProCA32.Collagen - Product Description
ProCA32.collagen+ - Product Status
ProCA32.collagen+ - Product Description
ProCA32.CXCR4 - Product Status
ProCA32.CXCR4 - Product Description
ProCA32.EGFR - Product Status
ProCA32.EGFR - Product Description
ProCA32.GRPR - Product Status
ProCA32.GRPR - Product Description
ProCA32.HER2 - Product Status
ProCA32.HER2 - Product Description
ProCA32.Integrin - Product Status
ProCA32.Integrin - Product Description
ProCA32.PD-L1 - Product Status
ProCA32.PD-L1 - Product Description
ProCA32.PSMA - Product Status
ProCA32.PSMA - Product Description
ProCA32.vEGFR - Product Status
ProCA32.vEGFR - Product Description
Inventera Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
INV-001 - Product Status
INV-001 - Product Description
INV-002 - Product Status
INV-002 - Product Description
INV-003 - Product Status
INV-003 - Product Description
Iowa State University Pipeline Products & Ongoing Clinical Trials Overview
Gd5Si4 MRI Contrast Agent - Product Status
Gd5Si4 MRI Contrast Agent - Product Description
King's College London Pipeline Products & Ongoing Clinical Trials Overview
Magnetic Resonance Contrast Agent - Product Status
Magnetic Resonance Contrast Agent - Product Description
Knowledgepie Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
Gd-Based Contrast Agent - Product Status
Gd-Based Contrast Agent - Product Description
LadeRx LLC Pipeline Products & Ongoing Clinical Trials Overview
Chelated Manganese-Based Contrast Agent - Product Status
Chelated Manganese-Based Contrast Agent - Product Description
Lantheus Medical Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview
LMI 1174 - Product Status
LMI 1174 - Product Description
Lipella Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
LP - 20 - Product Status
LP - 20 - Product Description
Lipella Pharmaceuticals Inc - Ongoing Clinical Trials Overview
LP - 20 - Human Clinical Study of a Novel Bladder MRI Contrast Agent
Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
Mn-PyC3A - Product Status
Mn-PyC3A - Product Description
MRI Contrast Agent - Product Status
MRI Contrast Agent - Product Description
Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
Metal-Free MRI Contrast Agent - Product Status
Metal-Free MRI Contrast Agent - Product Description
MRI-Based Calcium Sensor - Product Status
MRI-Based Calcium Sensor - Product Description
Molecular Theranostics LLC Pipeline Products & Ongoing Clinical Trials Overview
MRI Contrast Agent - Prostate Cancer (MT218) - Product Status
MRI Contrast Agent - Prostate Cancer (MT218) - Product Description
Molecular Theranostics LLC - Ongoing Clinical Trials Overview
MRI Contrast Agent - Prostate Cancer (MT218) - An Open-label Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent (MT218) in Prostate Cancer Patients
Nanosion Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Polymeric Gd Agent - Product Status
Polymeric Gd Agent - Product Description
National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview
Dual-Mode Contrast Agent - Product Status
Dual-Mode Contrast Agent - Product Description
Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
Gd(III) Contrast Agent - Product Status
Gd(III) Contrast Agent - Product Description
Peptide Amphiphile-Conjugated MRI Contrast Agent - Product Status
Peptide Amphiphile-Conjugated MRI Contrast Agent - Product Description
Polarean Imaging PLC Pipeline Products & Ongoing Clinical Trials Overview
HP 3He - Product Status
HP 3He - Product Description
XENOVIEW (xenon Xe 129 hyperpolarized) - Pediatrics - Product Status
XENOVIEW (xenon Xe 129 hyperpolarized) - Pediatrics - Product Description
QurCan Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Manganescan (T-MX) - Product Status
Manganescan (T-MX) - Product Description
Reveal Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
RVP-001 - Product Status
RVP-001 - Product Description
SG Endocrine Research LLC Pipeline Products & Ongoing Clinical Trials Overview
MRI Imaging Agent - Product Status
MRI Imaging Agent - Product Description
Signablok Inc Pipeline Products & Ongoing Clinical Trials Overview
Gadolinium-Based Contrast Agents - Product Status
Gadolinium-Based Contrast Agents - Product Description
Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview
Metabolic MRI Contrast Agent - Product Status
Metabolic MRI Contrast Agent - Product Description
SPION Based Imaging Agents - Product Status
SPION Based Imaging Agents - Product Description
SPAGO Nanomedical AB Pipeline Products & Ongoing Clinical Trials Overview
SN132D - Product Status
SN132D - Product Description
Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
Negative MR Contrast Agents - Product Status
Negative MR Contrast Agents - Product Description
Positive MR Contrast Agent - Product Status
Positive MR Contrast Agent - Product Description
SunTech Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
STD-002 - Product Status
STD-002 - Product Description
The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview
Nanoparticle Contrast Agent - Product Status
Nanoparticle Contrast Agent - Product Description
Theragnostic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Mangradex - Product Status
Mangradex - Product Description
University College London Pipeline Products & Ongoing Clinical Trials Overview
LipoGlucoCEST - Product Status
LipoGlucoCEST - Product Description
University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
Molecular Scaffold - Contrast Agent - Product Status
Molecular Scaffold - Contrast Agent - Product Description
University of Bordeaux Pipeline Products & Ongoing Clinical Trials Overview
Antibody Based Imaging Agent - Product Status
Antibody Based Imaging Agent - Product Description
University of Chicago Pipeline Products & Ongoing Clinical Trials Overview
MRI Imaging Agent - Ovarian Cancer - Product Status
MRI Imaging Agent - Ovarian Cancer - Product Description
University of Gottingen Pipeline Products & Ongoing Clinical Trials Overview
Iron paraCEST MRI Contrast Agent - Product Status
Iron paraCEST MRI Contrast Agent - Product Description
University of Louisville Pipeline Products & Ongoing Clinical Trials Overview
Voltage-Sensitive MRI Myelographic Contrast Agents - Product Status
Voltage-Sensitive MRI Myelographic Contrast Agents - Product Description
University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
Biodegradable MRI Imaging Agent - Product Status
Biodegradable MRI Imaging Agent - Product Description
Targeted Image Contrast Agent - Product Status
Targeted Image Contrast Agent - Product Description
University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview
Gadolinium Labeled Nanocluster - Product Status
Gadolinium Labeled Nanocluster - Product Description
Hyper-CEST MR Contrast Agent - Product Status
Hyper-CEST MR Contrast Agent - Product Description
University of Toronto Pipeline Products & Ongoing Clinical Trials Overview
MnTCP Imaging Agent - Product Status
MnTCP Imaging Agent - Product Description
MnTPPS3 Imaging Agent - Product Status
MnTPPS3 Imaging Agent - Product Description
Videns og Forskningscenter for Alternativ Behandling Pipeline Products & Ongoing Clinical Trials Overview
VLS-1 - Product Status
VLS-1 - Product Description
VLS-4 - Product Status
VLS-4 - Product Description
Voyageur Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
VY-101 - Product Status
VY-101 - Product Description
Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview
Colloidal Iron Oxide Contrast Agent - Product Status
Colloidal Iron Oxide Contrast Agent - Product Description
Wayne State University Pipeline Products & Ongoing Clinical Trials Overview
Next Generation MRI Contrast Imaging Agent - Product Status
Next Generation MRI Contrast Imaging Agent - Product Description
Weizmann Institute of Science Pipeline Products & Ongoing Clinical Trials Overview
Novel MRI Contrast Agent - Product Status
Novel MRI Contrast Agent - Product Description
Xemed LLC Pipeline Products & Ongoing Clinical Trials Overview
MagniXene - Product Status
MagniXene - Product Description
Xemed LLC - Ongoing Clinical Trials Overview
MagniXene - A Prospective Study of Hyperpolarized 129 Xe MRI in in a Pediatric Population with Bronchopulmonary Dysplasia
MagniXene - Functional and Structural Assessment of Endobronchial Valve Recipients Using Dynamic Hyperpolarized Xenon-129 MRI
MagniXene - Hyperpolarized 129 Xenon MRI in a Pediatric Population with Lung Transplant
MagniXene - New Strategies for Pulmonary Assessment in Spinal and Chest Wall Deformity
MagniXene - Pilot Study of Hyperpolarized Xenon Functional Lung Imaging in COPD Patients Undergoing Targeted Lung Denervation
Glossary

List of Figures

Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products by Stage of Development
Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products by Segment
Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products by Territory
Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products by Regulatory Path
Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products by Estimated Approval Date
Magnetic Resonance Imaging (MRI) Contrast Agents - Ongoing Clinical Trials